Avestha Gengraine Technologies Pvt. Ltd. (Avesthagen), one of India’s leading biotechnology companies based in Bangalore, announced that the Australian Patent Office has granted a patent to the company on "A process for generating cytoplasmic male sterile line in rice and other crops by RNA editing'. This patent will revolutionize the agricultural industry and bring succor to the sector. This invention promises to open up opportunities in developing hybrids in crops where conventional male sterility is not available or feasible. This technology would allow hybrid seed programs to be developed without narrowing the diversity of germplasm. Avesthagen assists farmers by creating innovative solutions that will benefit their production.Over the years Avesthagen has made numerous inventions and now it has a significant portfolio of 137 patent applications of which 61 relate to Agri-Biotech domain.
No comments:
Post a Comment